254 related articles for article (PubMed ID: 17046719)
1. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology.
Nelson CP; Challiss RA
Biochem Pharmacol; 2007 Mar; 73(6):737-51. PubMed ID: 17046719
[TBL] [Abstract][Full Text] [Related]
2. Emerging concepts in GPCR function--the influence of cell phenotype on GPCR pharmacology.
Eglen RM
Proc West Pharmacol Soc; 2005; 48():31-4. PubMed ID: 16416655
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
Bond RA; Ijzerman AP
Trends Pharmacol Sci; 2006 Feb; 27(2):92-6. PubMed ID: 16406086
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor pharmacogenetics.
Thompson MD; Siminovitch KA; Cole DE
Methods Mol Biol; 2008; 448():139-85. PubMed ID: 18370234
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
Seifert R; Wenzel-Seifert K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):381-416. PubMed ID: 12382069
[TBL] [Abstract][Full Text] [Related]
6. Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor.
Zeng FY; McLean AJ; Milligan G; Lerner M; Chalmers DT; Behan DP
Mol Pharmacol; 2003 Dec; 64(6):1474-84. PubMed ID: 14645678
[TBL] [Abstract][Full Text] [Related]
7. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Sep; 64(3):679-88. PubMed ID: 12920204
[TBL] [Abstract][Full Text] [Related]
8. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
DeWire SM; Violin JD
Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
[TBL] [Abstract][Full Text] [Related]
9. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
Seifert R; Dove S
Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
[TBL] [Abstract][Full Text] [Related]
10. Signaling mechanisms of GPCR ligands.
Strange PG
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):196-202. PubMed ID: 18283607
[TBL] [Abstract][Full Text] [Related]
11. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
Hancock AA
Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092
[TBL] [Abstract][Full Text] [Related]
12. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
Kent T; McAlpine C; Sabetnia S; Presland J
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
14. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
15. Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing?
Greasley PJ; Clapham JC
Eur J Pharmacol; 2006 Dec; 553(1-3):1-9. PubMed ID: 17081515
[TBL] [Abstract][Full Text] [Related]
16. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification.
Lee PH
J Recept Signal Transduct Res; 2009; 29(3-4):146-53. PubMed ID: 19594401
[TBL] [Abstract][Full Text] [Related]
17. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
Gilchrist A
Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
[TBL] [Abstract][Full Text] [Related]
18. A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: evidence for differential inverse agonism.
Dowling MR; Willets JM; Budd DC; Charlton SJ; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2006 Jun; 317(3):1134-42. PubMed ID: 16489127
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
Thompson MD; Cole DE; Jose PA
Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
[TBL] [Abstract][Full Text] [Related]
20. GPCR activation: a mutagenic spotlight on crystal structures.
Hulme EC
Trends Pharmacol Sci; 2013 Jan; 34(1):67-84. PubMed ID: 23245528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
